Kevin J. McNamara has been leading Chemed Corporation since 2006. He holds an MBA from Harvard Business School and brings extensive experience in business management to the company. Under his leadership, Chemed has seen significant financial growth, notably increasing its...

Kevin J. McNamara has been leading Chemed Corporation since 2006. He holds an MBA from Harvard Business School and brings extensive experience in business management to the company. Under his leadership, Chemed has seen significant financial growth, notably increasing its earnings by an impressive 10.9% annually from 2008 to 2010. Kevin's approach focuses on aligning executive compensation with company performance, using metrics like Adjusted Earnings Per Share (EPS) and Return on Assets. This aligns incentives with the company's broader goals. As of 2023, his total compensation package was around $12.6 million, with a strong emphasis on performance-based incentives that account for a large percentage of his earnings. Interestingly, Kevin's wealth is highly tied to Chemed's stock; he holds shares worth around 20 times his salary. This creates a direct link between his performance and shareholder value, which reflects a strong commitment to the company's success. It's worth noting that he also has a solid plan in place for retirement benefits and a severance package should he leave the company.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

C

Kevin J. McNamara

CEO of Chemed

Education

Bachelor's degree from Denison University and an MBA from the University of Cincinnati

Field of Expertise

Finance & Banking - Finance

Sector of Economy

Healthcare

Born

July 1, 1948 - 76 years ago

CEO of Chemed for

23 years 8 months (Aug 2001 - Present)

Previous Experience

President of Omnicare, Inc.

Rivals

Competitors/colleagues of Kevin J. McNamara

M

August J. Troendle

Founder and CEO of Medpace Holdings, Inc.

2023 Compensation

Stock

$0.00

Salary

$825.00K

Bonus

$814.42K

Other

$17.33K

Total Holdings

$1.76B

Holdings

See how much did Kevin J. McNamara make over time.

Kevin J. McNamara's financial portfolio is closely tied to Chemed Corporation, where he has been CEO since 2006. His stock holdings were valued at approximately $162.81 million in August 2024, indicating that a significant portion of his wealth is invested...

Kevin J. McNamara's financial portfolio is closely tied to Chemed Corporation, where he has been CEO since 2006. His stock holdings were valued at approximately $162.81 million in August 2024, indicating that a significant portion of his wealth is invested in the company he oversees. This shows a strong commitment to Chemed's performance, as his financial success is tied to the company's stock price. Over the years, his shareholding has soared, reflecting not only his influence within the company but also his belief in its potential for growth and profitability. He holds shares that equate to around 20 times his salary, which underscores the alignment of his interests with those of shareholders. Such a strategy is part of his broader philosophy of incentivizing leadership based on the company's success and performance metrics. This approach creates a powerful motivation to drive long-term growth and shareholder value.

Total Stock Sold

$115.13M

CHE

$115.13M

465,227 CHE shares

What if they kept their stock?

If Kevin J. McNamara didn't sell their stock, today they would have:
Extra CHE465,227 shares worth $198.28M.
This is 72.22% and $83.15M more than what they got when they sold the stock.

Charitable Transactions

CHE

358 shares

CHE

Recent Charitable Transactions

CHE

$50.39K

CHE at $203.18/share

Apr 28, 2017

Charity

CHE

$9.98K

CHE at $90.72/share

Nov 4, 2014

Charity

Insider Trading

See recent insider trades of Kevin J. McNamara.

CHE

$1.19M

CHE at $593.67/share

Mar 6, 2025

Sale

CHE

$1.15M

CHE at $572.77/share

Nov 25, 2024

Sale

CHE

$1.20M

CHE at $598.81/share

Sep 26, 2024

Sale

CHE

$1.14M

CHE at $569.63/share

Aug 5, 2024

Sale

CHE

$816.25K

CHE at $544.17/share

Jun 6, 2024

Sale

CHE

$2.27M

CHE at $567.54/share

May 16, 2024

Sale

CHE

$859.16K

CHE at $572.77/share

Dec 11, 2023

Sale

CHE

$2.80M

CHE at $560.68/share

Oct 31, 2023

Sale

CHE

$2.07M

CHE at $516.43/share

Aug 3, 2023

Sale

CHE

$2.20M

CHE at $549.34/share

May 5, 2023

Sale

Compensation History

See how much did Kevin J. McNamara make over time.

Kevin J. McNamara's compensation at Chemed Corporation reflects a performance-oriented structure. In 2023, his total pay was approximately $12.6 million, which includes a salary of $1.6 million and a bonus of $2.9 million linked to key performance metrics. The focus is on long-term growth, with significant portions of his earnings resulting from vested stock options and other incentives based on the company's success. For example, he received about $4.2 million from stock options that vested this year. Chemed's compensation philosophy is about keeping executive pay aligned with performance, which means if the company does well, he benefits more as well. This strategy helps ensure that leaders like Kevin are motivated not just by their base salary but also by the overall success of the company.

Year

2023

Total Compensation

$7.10M

Salary

$1.60M

Board Justification

The compensation philosophy aligns executive compensation with company performance, focusing on long-term growth and retention strategies.

Bonus

$2.92M

Board Justification

Annual cash incentive compensation based on performance metrics including Adjusted EPS and Return on Assets for 2023.

Other

$1.31M

Board Justification

Includes contributions to non-qualified deferred compensation plans, personal use of company aircraft, and other perquisites.

Restricted Stock

$1.26M(2.51M RSU)

Board Justification

Value of stock awards that vested in 2023, based on performance share units granted in prior years.

Performance Metrics

Adjusted EPS and Return on Assets targets are used to determine the annual cash incentive compensation.